IDX.AX ASX
Integral Diagnostics Limited
1W: -2.7%
1M: -5.7%
3M: +2.4%
YTD: -13.7%
1Y: -24.6%
3Y: -25.9%
5Y: -47.8%
A$2.13 ($1.48)
-0.02 (-0.93%)
Weekly Expected Move ±2.7%
A$2
A$2
A$2
A$2
A$2
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$95M
+29.1% ▲
5Y CAGR: +6.5%
Capital Expenditures
$50M
+16.9% ▲
5Y CAGR: +19.6%
Free Cash Flow
$46M
+225.4% ▲
5Y CAGR: -1.5%
Dividends Paid
$26M
-67.7% ▼
Buybacks
$2M
+0.0% ▲
Net Change in Cash
-$818K
-108.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $15M | $25M | -$61M | $0 | $22M |
| Depreciation & Amort. | $37M | $43M | $47M | $0 | $74M |
| Stock-Based Comp. | -$1M | $3M | $2M | $0 | $0 |
| Change in Working Capital | -$12M | $14M | $4M | $12M | -$9M |
| Other Non-Cash Items | -$844K | -$12M | $74M | $62M | $8M |
| Operating Cash Flow | $37M | $71M | $66M | $74M | $95M |
| — Investing Activities — | |||||
| Capital Expenditures | -$28M | -$44M | -$24M | -$60M | -$50M |
| Acquisitions (Net) | -$25M | -$85M | $0 | -$6M | $3M |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$3M | -$150K | -$4M | $313K | $0 |
| Investing Cash Flow | -$56M | -$129M | -$28M | -$65M | -$46M |
| — Financing Activities — | |||||
| Net Debt Issuance | $24M | -$2M | -$2M | $35M | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | -$2M |
| Dividends Paid | -$21M | -$13M | -$14M | -$15M | -$26M |
| Other Financing | -$14M | -$19M | -$15M | -$19M | -$21M |
| Financing Cash Flow | $81M | -$32M | -$29M | $710K | -$48M |
| Net Change in Cash | $61M | -$89M | $9M | $10M | -$818K |
| Cash End of Period | $123M | $34M | $42M | $52M | $51M |
| Free Cash Flow | $9M | $27M | $42M | $14M | $46M |